跳至主要内容
临床试验/NL-OMON46598
NL-OMON46598招募中不适用

Ajmaline provocation in early detection of Arrhythmogenic Cardiomyopathy - Ajmaline provocation in early detection of Arrhythmogenic Cardiomyopathy

niversitair Medisch Centrum Utrecht0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age >=18 years
  • Pathogenic PLN mutation, pathogenic PKP2 mutation or patients without structural heart disease who are referred for ajmaline provocation to exclude Brugada syndrome.
  • Referral for cardiac MRI during routine clinical practice
  • New York Heart Association functional class <= 1.

排除标准

  • Severe hepatic impairment (Child-Pugh class C)
  • Severe renal dysfunction (eGFR <30 ml/min/kg)
  • Symptomatic heart failure, NYHA >= 2
  • Women who are currently pregnant
  • Known intolerance or contraindication to Ajmaline
  • Sick sinus syndrome, second or third degree AV block
  • Recent myocardial infarction
  • Known strong allergic reaction to ECG electrodes
  • Current use of anti-arrhythmic drugs (Bruagdadrugs.org list class I, IIa, IIb)
  • Current or recent use of amiodarone (within 6 months)

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验